MedTrace Logo

Clinical Test of the MRgHIFU System on Uterine Fibroids

NCT02283502 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-11-05

No results posted yet for this study

Summary

The objectives of this program are to verify the safety and effectiveness of the MRgHIFU system developed by the division of Medical Engineering of National Health Research Institutes (NHRI)

Conditions

  • Uterine Fibroids

Interventions

DEVICE

MRgHIFU system

Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) system for the noninvasive treatment of uterine fibroids

Sponsors & Collaborators

  • National Health Research Institutes, Taiwan

    collaborator OTHER

  • Chin-Jung Wang

    lead OTHER

Principal Investigators

  • Chin-Jung Wang, MD · Chang Gung Memorial Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02283502 on ClinicalTrials.gov